The Phase III human clinical trials of COVAXIN began mid-November, targeted to be done in 26,000 volunteers across India, this is India’s first and only Phase III efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India. COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results, with acceptance in international peer reviewed scientific journals.

COVAXIN, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). This indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment facility, one of its kind in the world.

COVAXIN is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses.

Meanwhile, India has registered several landmark achievements in the fight against the global pandemic today.

India’s active caseload has fallen below 3 lakh (2,92,518)today. The share of Active Cases in the total Positive Cases has further shrunk below 3% to 2.90%. This is lowest after 163 days. The total active cases were 2,92,258 on 12th July, 2020.

A net decline of 11,121cases has been recorded in the total active cases in last 24 hours. India has achieved a new low in daily cases. Less than 20,000 daily new cases (19,556)were added to the national tally in the last 24 hours after 173 days. The new added cases were 19,148 on 2nd July, 2020.

India’s active cases per million population are amongst the lowest in the world (219). The figure is much higher for countries like USA, Italy, Brazil, Turkey and Russia. The total recovered cases have crossed 96 lakhs (96,36,487) which translates to a Recovery Rate of 95.65%. The gap between Recovered cases and Active cases continues to grow and presently stands at 93,43,969.

30,376 cases have recovered in the last 24 hours. New recoveries have been exceeding the new cases continuously since last 25 days.